CORT - Corcept Therapeutics Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
73.5 4.0 (5.44%)	---	---	0.85 (1.11%)	-1.37 (-1.86%)	4.48 (6.19%)	0.0 (0.0%)	0.0 (0.0%)

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: 0.33
Diluted EPS:: 0.29
Basic P/E:: 234.8485
Diluted P/E:: 267.2414
RSI(14) 1m:: 100.0
VWAP:: 77.62
RVol:: 1.172

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	73.21 -0.81 (-1.09%)	Oct 15 09:36
1m	Price increase 1m	75.04 +1.02 (+1.38%)	Oct 15 09:34
1m	Price increase 1m	74.59 +1.62 (+2.22%)	Oct 15 09:32
10m	Price increase 10m	74.59 +2.26 (+3.12%)	Oct 15 09:32